The pharmaceutical industry's commitment to addressing dry age-related macular degeneration has intensified significantly, with numerous investigational compounds advancing through various clinical development stages, offering hope to patients who currently lack disease-modifying treatment options. The dry age related macular degeneration amd market forecast indicates substantial revenue...